3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference to be held on 28th – 29th October 2021 will host industry giants like Advanced Cell & Gene Therapy LLC, Cell & Gene Therapy Consulting LLC, panCella, Sigilon Inc, Biotechnology Biopharmaceuticals and many more. The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7 billion in 2021, at a CAGR of 12.4% during the forecast period. Growth in this market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical R&D, investments in advanced technologies by CDMOs, and increasing partnerships & agreements between pharmaceutical companies and CDMOs.
KEY HIGHLIGHTS
- Cell culture through dimensional process
- Lentiviral bioprocessing
- Automation of cellular therapies
- AAV vector production
- Process development and monitoring of cell-gene therapies
- CMC considerations for NK cells
- Supply chain and regulatory issues
Companies like Gyros Protein Technologies, CPC and QOSINA are all set to showcase their products, solutions, case studies at this 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.
The event overview, registration details and complete speaker list are available on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – https://bit.ly/3i8Y87B or you can directly email on events@marketsandmarkets.com asking for more details, your queries and provide feedback.
Markets and Markets Conferences (MnM Conferences) produces global summits, congresses and conferences bringing together key industry experts from academia and industry, fostering the exchange of ideas and latest research through cutting edge conference programs, interactive panel and round table discussions. Conferences are currently being held virtually.
Contact Person – Akshat Chauhan
Email: akshat.chauhan@marketsandmarkets.com
